A novel role for histone deacetylase 6 in the regulation of the tolerogenic STAT3/IL-10 pathway in APCs
Open accessAbstract
APCs are critical in T cell activation and in the induction of T cell tolerance. Epigenetic modifications of specific genes in the APC play a key role in this process, and among them histone deacetylases (HDACs) have emerged as key participants. HDAC6, one of the members of this family of enzymes, has been shown to be involved in regulation of inflammatory and immune responses. In this study, to our knowledge we show for the first time that genetic or pharmacologic disruption of HDAC6 in macrophages and dendritic cells results in diminished production of the immunosuppressive cytokine IL-10 and induction of inflammatory APCs that effectively activate Ag-specific naive T cells and restore the responsiveness of anergic CD4+ T cells. Mechanistically, we have found that HDAC6 forms a previously unknown molecular complex with STAT3, association that was detected in both the cytoplasmic and nuclear compartments of the APC. By using HDAC6 recombinant mutants we identified the domain comprising amino acids 503–840 as being required for HDAC6 interaction with STAT3. Furthermore, by re–chromatin immunoprecipitation we confirmed that HDAC6 and STAT3 are both recruited to the same DNA sequence within the Il10 gene promoter. Of note, disruption of this complex by knocking down HDAC6 resulted in decreased STAT3 phosphorylation—but no changes in STAT3 acetylation—as well as diminished recruitment of STAT3 to the Il10 gene promoter region. The additional demonstration that a selective HDAC6 inhibitor disrupts this STAT3/IL-10 tolerogenic axis points to HDAC6 as a novel molecular target in APCs to overcome immune tolerance and tips the balance toward T cell immunity.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
STAT3-HDAC6 transcriptionally upregulates IL-10, preventing effective antigen-specific CD4+ T cell activation in tumor-bearing mice.
“STAT3–HDAC6 transcriptionally upregulates IL-10, preventing effective Ag-specific CD4+ T cell activation in tumor-bearing mice”
From Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution (2020) · cites this paper as Cheng et al., 2014
The Discussion describes HDAC6 and STAT3 as regulators of Il10 transcription in APCs, and the Results show that disrupting HDAC6 improves antigen-specific CD4+ T-cell activation. In the tumor-bearing-mouse model, however, the paper tested re-isolated tolerant T cells with HDAC6-deficient APCs in vitro; it does not show that the STAT3–HDAC6–IL-10 pathway prevented their activation within tumor-bearing mice. Page numbers are unavailable in our copy. (LLM, conf=0.84)
Experimental — accuracy not yet measuredUse of an HDAC inhibitor enabled effective T cell priming and antitumor response.
“use of a HDAC inhibitor enabled effective T cell priming and antitumor response”
From Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution (2020) · cites this paper as Cheng et al., 2014
The Results section reports that the HDAC6 inhibitor Tubastatin A enhanced antigen-specific CD4+ T-cell activation and priming, including in vaccinated mice. It also restored responsiveness of T cells isolated from tumor-bearing mice, but does not report an antitumor response such as reduced tumor growth or rejection (page numbers unavailable). (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610 · see citing works
The regulation of IL-10 production by immune cells
Saraiva, M., & O’Garra, A. (2010) · Nature reviews. Immunology · doi:10.1038/nri2711 · Cited by 3,185 · see citing works
Histone deacetylases (HDACs): characterization of the classical HDAC family
RUIJTER, A. J. M. D., GENNIP, A. H. V., CARON, H. N., KEMP, S., & KUILENBURG, A. B. P. V. (2003) · Biochemical Journal · doi:10.1042/bj20021321 · Cited by 3,114 · see citing works
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559 · see citing works
HDAC6 is a microtubule-associated deacetylase
Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P. (2002) · Nature · doi:10.1038/417455a · Cited by 2,403 · see citing works
Nasir, O. (2013) · Kidney & Blood Pressure Research · doi:10.1159/000350152 · Cited by 2,331 · see citing works
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1779 · Cited by 2,211 · see citing works
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977 · see citing works
Regulatory T Cell-Derived Interleukin-10 Limits Inflammation at Environmental Interfaces
Rubtsov, Y. P., Rasmussen, J. P., Chi, E. Y., Fontenot, J., Castelli, L., Ye, X., Treuting, P., Siewe, L., Roers, A., Henderson, W. R., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.017 · Cited by 1,586 · see citing works
Acetylation and deacetylation of non-histone proteins
Glozak, M. A., Sengupta, N., Zhang, X., & Seto, E. (2005) · Gene · doi:10.1016/j.gene.2005.09.010 · Cited by 1,584 · see citing works
Self-citationBarnden, M., Allison, J., Heath, W. R., & Carbone, F. (1998) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.1998.00709.x · Cited by 1,491 · see citing works
Gene-specific control of inflammation by TLR-induced chromatin modifications
Foster, S. L., Hargreaves, D. C., & Medzhitov, R. (2007) · Nature · doi:10.1038/nature05836 · Cited by 1,344 · see citing works
The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
Yang, X., & Seto, E. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2346 · Cited by 1,239 · see citing works
Self-citationMarks, P. A., & Breslow, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1272 · Cited by 1,198 · see citing works
The JAK-STAT Signaling Pathway: Input and Output Integration
Murray, P. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2623 · Cited by 1,179 · see citing works
Transcriptional control of the inflammatory response
Medzhitov, R., & Horng, T. (2009) · Nature Reviews Immunology · doi:10.1038/nri2634 · Cited by 1,035 · see citing works
Histone deacetylases and cancer
Glozak, M. A., & Seto, E. (2007) · Oncogene · doi:10.1038/sj.onc.1210610 · Cited by 1,031 · see citing works
Self-citationMurai, M., Turovskaya, O., Kim, G., Madan, R., Karp, C. L., Cheroutre, H., & Kronenberg, M. (2009) · Nature Immunology · doi:10.1038/ni.1791 · Cited by 851 · see citing works
Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
Butler, K. V., Kalin, J., Brochier, C., Vistoli, G., Langley, B., & Kozikowski, A. P. (2010) · Journal of the American Chemical Society · doi:10.1021/ja102758v · Cited by 801 · see citing works
Self-citationStat3 Dimerization Regulated by Reversible Acetylation of a Single Lysine Residue
Yuan, Z.-L., Guan, Y.-J., Chatterjee, D., & Chin, Y. E. (2005) · Science · doi:10.1126/science.1105166 · Cited by 790 · see citing works
Wakkach, A., Fournier, N., Brun, V., Breittmayer, J., Cottrez, F., & Groux, H. (2003) · Immunity · doi:10.1016/s1074-7613(03)00113-4 · Cited by 788 · see citing works
HDAC6 Modulates Cell Motility by Altering the Acetylation Level of Cortactin
Zhang, X. M., Yuan, Z., Zhang, Y., Yong, S., Salas-Burgos, A., Koomen, J. M., Olashaw, N., Parsons, J. T., Yang, X., Dent, S., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.033 · Cited by 731 · see citing works
Self-citationInduction of antigen-specific T cell anergy: An early event in the course of tumor progression
Staveley-O’Carroll, K. F., Sotomayor, E. M., Montgomery, J., Borrello, I., Hwang, L., Fein, S., Pardoll, D. M., & Levitsky, H. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1178 · Cited by 702 · see citing works
Self-citationRegulation of activity of the transcription factor GATA-1 by acetylation
Boyes, J., Byfield, P., Nakatani, Y., & Ogryzko, V. (1998) · Nature · doi:10.1038/25166 · Cited by 694 · see citing works
Mice Lacking Histone Deacetylase 6 Have Hyperacetylated Tubulin but Are Viable and Develop Normally
Zhang, Y., Kwon, S., Yamaguchi, T., Cubizolles, F., Rousseaux, S., Kneissel, M., Cao, C., Li, N., Cheng, H.-L., Chua, K., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01154-06 · Cited by 559 · cited 2× · see citing works
“Matthias (32) (Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland).”
BackgroundContextual Regulation of Inflammation: A Duet by Transforming Growth Factor-β and Interleukin-10
Li, M. O., & Flavell, R. A. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.003 · Cited by 501 · see citing works
HDAC6: a key regulator of cytoskeleton, cell migration and cell–cell interactions
Valenzuela-Fernández, A., Cabrero, J. R., Serrador, J. M., & Sánchez‐Madrid, F. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.04.003 · Cited by 500 · see citing works
The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance
Villagra, A., Cheng, F., Wang, H.-W., Suarez, I., Glozak, M., Maurin, M., Nguyen, D., Wright, K. L., Atadja, P. W., Bhalla, K., et al. (2009) · Nature Immunology · doi:10.1038/ni.1673 · Cited by 455 · see citing works
Self-citationKirberg, J., Baron, A., Jakob, S. M., Rolink, A. G., Karjalainen, K., & von Boehmer, H. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.1.25 · Cited by 410 · see citing works
Sotomayor, E. M., Borrello, I., Tubb, E. E., Rattis, F., Bien, H., Lu, Z., Fein, S., Schoenberger, S. P., & Levitsky, H. I. (1999) · Nature Medicine · doi:10.1038/10503 · Cited by 406 · see citing works
Self-citationA Critical Role for Stat3 Signaling in Immune Tolerance
Cheng, F., Wang, H.-W., Cuenca, A., Huang, M., Ghansah, T., Brayer, J., Kerr, W. G., Takeda, K., Akira, S., Schoenberger, S. P., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00232-2 · Cited by 377 · see citing works
Self-citationAldana-Masangkay, G. I., & Sakamoto, K. M. (2010) · BioMed Research International · doi:10.1155/2011/875824 · Cited by 375 · see citing works
Niemand, C., Nimmesgern, A., Haan, S., Fischer, P., Schaper, F., Rossaint, R., Heinrich, P. C., & Müller-Newen, G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3263 · Cited by 357 · see citing works
Histone deacetylase 6–mediated selective autophagy regulates COPD-associated cilia dysfunction
Lam, H. C., Cloonan, S. M., Bhashyam, A. R., Haspel, J. A., Singh, A., Sathirapongsasuti, J. F., Cervo, M., Yao, H., Chung, A. L., Mizumura, K., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69636 · Cited by 307 · see citing works
New insights into the molecular mechanism of interleukin-10-mediated immunosuppression
Grütz, G. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0904484 · Cited by 296 · see citing works
Wang, R., Cherukuri, P., & Luo, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413930200 · Cited by 275 · see citing works
Vorinostat for Treatment of Cutaneous Manifestations of Advanced Primary Cutaneous T-Cell Lymphoma
Mann, B. S., Johnson, J. R., He, K., Sridhara, R., Abraham, S., Booth, B. P., Verbois, L., Morse, D. E., Jee, J. M., Pope, S., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2672 · Cited by 264 · see citing works
Histone Deacetylase 6 and Heat Shock Protein 90 Control the Functions of Foxp3 + T-Regulatory Cells
de Zoeten, E. F., Wang, L., Butler, K. V., Beier, U. H., Akimova, T., Sai, H., Bradner, J. E., Mazitschek, R., Kozikowski, A. P., Matthias, P., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05155-11 · Cited by 257 · see citing works
Self-citationE2F Family Members Are Differentially Regulated by Reversible Acetylation
Marzio, G., Wagener, C., Gutiérrez, M. I., Cartwright, P., Helin, K., & Giacca, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.10887 · Cited by 231 · see citing works
Active maintenance of mHDA2/mHDAC6 histone-deacetylase in the cytoplasm
Verdel, A., Curtet, S., Brocard, M.-P., Rousseaux, S., Lemercier, C., Yoshida, M., & Khochbin, S. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00542-x · Cited by 224 · see citing works
Bergman, J. A., Woan, K. V., Perez-Villarroel, P., Villagra, A., Sotomayor, E. M., & Kozikowski, A. P. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301098e · Cited by 200 · see citing works
Self-citationHDAC6 Deacetylase Activity Links the Tubulin Cytoskeleton with Immune Synapse Organization
Serrador, J. M., Cabrero, J. R., Sancho, D., Mittelbrunn, M., Urzainqui, A., & Sánchez‐Madrid, F. (2004) · Immunity · doi:10.1016/s1074-7613(04)00078-0 · Cited by 193 · see citing works
Kozikowski, A. P., Tapadar, S., Luchini, D. N., Kim, K. H., & Billadeau, D. D. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8002894 · Cited by 190 · see citing works
Self-citationHalili, M. A., Andrews, M. R., Labzin, L. I., Schroder, K., Matthias, G., Cao, C., Lovelace, E., Reid, R. C., Le, G. T., Hume, D. A., et al. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0509363 · Cited by 186 · see citing works
Gupta, M., Ansell, S. M., Novak, A. J., Kumar, S. K., Kaufmann, S. H., & Witzig, T. E. (2009) · Blood · doi:10.1182/blood-2009-05-220889 · Cited by 163 · see citing works
Liu, Y., Peng, L., Seto, E., Huang, S., & Qiu, Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.371120 · Cited by 144 · see citing works
Self-citationInterleukin‐10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice
Han, X., Kitamoto, S., Wang, H., & Boisvert, W. A. (2010) · The FASEB Journal · doi:10.1096/fj.09-148155 · Cited by 143 · see citing works
Self-citationCheng, F., Lienlaf, M., Perez-Villarroel, P., Wang, H.-W., Lee, C., Woan, K., Woods, D., Knox, T., Bergman, J., Pinilla-Ibarz, J., et al. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.02.019 · Cited by 140 · see citing works
Self-citationRomidepsin for the treatment of cutaneous T-cell lymphoma
Campàs-Moya, C. (2009) · Drugs of today · doi:10.1358/dot.2009.45.11.1437052 · Cited by 138 · see citing works
Deactylase Inhibitors Disrupt Cellular Complexes Containing Protein Phosphatases and Deacetylases
Brush, M., Guardiola, A. R., Connor, J. H., Yao, T., & Shenolikar, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310997200 · Cited by 128 · see citing works
Ferguson, B. S., Harrison, B. C., Jeong, M. Y., Reid, B. G., Wempe, M. F., Wagner, F. F., Holson, E. B., & McKinsey, T. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301509110 · Cited by 108 · see citing works
Jung, K. H., Noh, J. H., Kim, J. K., Eun, J. W., Bae, H. J., Chang, Y. G., Kim, M., Park, W. S., Lee, J. Y., Lee, S.-Y., et al. (2012) · Hepatology · doi:10.1002/hep.25699 · Cited by 108 · see citing works
Ray, S., Lee, C., Hou, T., Boldogh, I. R., & Brasier, A. R. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn419 · Cited by 90 · see citing works
Self-citationSotomayor, E. M., Fu, Y., Lopez-Cepero, M. M., Herbert, L. M., Jimenez, J. J., Albarracin, C. T., & Lopez, D. M. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.8.2816 · Cited by 86 · see citing works
Self-citationVillagra, A., Cruzat, F., Carvallo, L., Paredes, R., Olate, J., van Wijnen, A. J., Stein, G. S., Lian, J. B., Stein, J. L., Imbalzano, A. N., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511640200 · Cited by 78 · see citing works
Self-citationToropainen, S., Vaïsänen, S., Heikkinen, S., & Carlberg, C. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.05.031 · Cited by 75 · see citing works
Modulation of antigen‐presenting cells by HDAC inhibitors: implications in autoimmunity and cancer
Woan, K. V., Sahakian, E., Sotomayor, E. M., Seto, E., & Villagra, A. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2011.96 · Cited by 71 · see citing works
Self-citationFunction of Histone Deacetylase 6 as a Cofactor of Nuclear Receptor Coregulator LCoR
Palijan, A., Fernandes, I., Bastien, Y., Tang, L., Verway, M., Kourelis, M., Tavera-Mendoza, L. E., Li, Z., Bourdeau, V., Mader, S., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.045526 · Cited by 65 · see citing works
Brender, C., Tannahill, G. M., Jenkins, B. J., Fletcher, J. G., Columbus, R., Saris, C. J. M., Ernst, M., Nicola, N. A., Hilton, D. J., Alexander, W. S., et al. (2007) · Blood · doi:10.1182/blood-2006-08-041541 · Cited by 64 · see citing works
Wang, H., Cheng, F., Woan, K. V., Sahakian, E., Merino, O., Rock-Klotz, J. A., Vicente-Suarez, I., Pinilla-Ibarz, J. A., Wright, K. L., Seto, E., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001101 · Cited by 54 · see citing works
Self-citationHDAC3 influences phosphorylation of STAT3 at serine 727 by interacting with PP2A
Togi, S., Kamitani, S., Kawakami, S., Ikeda, O., Muromoto, R., Nanbo, A., & Matsuda, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.132 · Cited by 51 · see citing works
Identification of a novel negative role of flagellin in regulating IL‐10 production
Vicente-Suarez, I., Takahashi, Y., Cheng, F., Horna, P., Wang, H. W., Wang, H., & Sotomayor, E. M. (2007) · European Journal of Immunology · doi:10.1002/eji.200737306 · Cited by 27 · see citing works
Self-citationFrom immunity to tolerance through HDAC
Georgopoulos, K. (2008) · Nature Immunology · doi:10.1038/ni0109-13 · Cited by 20 · see citing works
Flagged first, then by citations
1 of the 64 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Histone Deacetylase Inhibitors as Anticancer Drugs
Eckschlager, T., Plch, J., Stiborova, M., & Hrabeta, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071414 · Cited by 1,206 · see citing works
Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells
Li, M., van Esch, B. C. A. M., Wagenaar, G. T. M., Garssen, J., Folkerts, G., & Henricks, P. A. J. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.05.003 · Cited by 622 · see citing works
Histone deacetylase 6 in cancer
Li, T., Zhang, C., Hassan, S., Liu, X., Song, F., Chen, K., Zhang, W., & Yang, J. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0654-9 · Cited by 330 · see citing works
The emerging role of epigenetics in human autoimmune disorders
Mazzone, R., Zwergel, C., Artico, M., Taurone, S., Ralli, M., Greco, A., & Mai, A. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0632-2 · Cited by 318 · see citing works
Hull, E. E., Montgomery, M. R., & Leyva, K. J. (2016) · BioMed Research International · doi:10.1155/2016/8797206 · Cited by 316 · see citing works
Bharadwaj, U., Kasembeli, M. M., Robinson, P., & Tweardy, D. J. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018440 · Cited by 314 · see citing works
“, 2014), while using an HDACi, ↑effective T cell priming and antitumor response (Wang et al., 2011a; Cheng et al., 2014) Inhibition Preclinical”
BackgroundMethodInfluentialEssential role of HDAC6 in the regulation of PD‐L1 in melanoma
Lienlaf, M., Perez-Villarroel, P., Knox, T. J., Pabon, M. M., Sahakian, E., Powers, J. J., Woan, K. V., Lee, C., Cheng, F., Deng, S., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2015.12.012 · Cited by 171 · see citing works
Self-citationKnox, T., Sahakian, E., Banik, D., Hadley, M., Palmer, E., Noonepalle, S., Kim, J., Powers, J., Gracia-Hernandez, M., Oliveira, V., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42237-3 · Cited by 170 · see citing works
Self-citationAdeegbe, D. O., Liu, Y., Lizotte, P. H., Kamihara, Y., Aref, A. R., Almonte, C. G., Dries, R., Li, Y., Liu, S., Wang, X., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1020 · Cited by 150 · see citing works
Woan, K. V., Lienlaf, M., Perez-Villarroel, P., Lee, C., Cheng, F., Knox, T. J., Woods, D. M., Barrios, K., Powers, J. J., Sahakian, E., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.04.002 · Cited by 138 · see citing works
Self-citationImmunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy
Banik, D., Moufarrij, S., & Villagra, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092241 · Cited by 134 · see citing works
Self-citationRegulatory dendritic cells in autoimmunity: A comprehensive review
Liu, J., & Cao, X. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.07.011 · Cited by 133 · see citing works
STAT3, a master regulator of anti-tumor immune response
Rébé, C., & Ghiringhelli, F. (2019) · Cancers · doi:10.3390/cancers11091280 · Cited by 129 · see citing works
de Groot, A. E., & Pienta, K. J. (2018) · Oncotarget · doi:10.18632/oncotarget.24556 · Cited by 122 · see citing works
Knox, T. J., Sahakian, E., Banik, D., Hadley, M. M., Palmer, E., Noonepalle, S. K. R., Kim, J. S., Powers, J. J., Gracia-Hernandez, M., Oliveira, V. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-51403-6 · Cited by 118 · see citing works
Self-citationMoufarrij, S., Srivastava, A., Gomez, S., Hadley, M. M., Palmer, E., Austin, P. T., Chisholm, S., Diab, N., Roche, K. C., Yu, A. Y. C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-60409-4 · Cited by 117 · see citing works
Self-citationThe Emerging Role of Epigenetics in Autoimmune Thyroid Diseases
Wang, B., Shao, X., Song, R., Xu, D., & Zhang, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00396 · Cited by 99 · see citing works
Li, A., Chen, P., Leng, Y., & Kang, J. (2018) · Oncogene · doi:10.1038/s41388-018-0379-9 · Cited by 91 · see citing works
Gatla, H. R., Muniraj, N., Thevkar, P., Yavvari, S., Sukhavasi, S., & Makena, M. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051110 · Cited by 91 · see citing works
Recent Update of HDAC Inhibitors in Lymphoma
Chen, I., Sethy, B., & Liou, J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.576391 · Cited by 86 · see citing works
The therapeutic hope for HDAC6 inhibitors in malignancy and chronic disease
Batchu, S. N., Brijmohan, A. S., & Advani, A. (2016) · Clinical Science · doi:10.1042/cs20160084 · Cited by 84 · see citing works
HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics
Laino, A. S., Betts, B. C., Veerapathran, A., Dolgalev, I., Sarnaik, A. A., Quayle, S. N., Jones, S. S., Weber, J. S., & Woods, D. M. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0517-0 · Cited by 82 · see citing works
Self-citationWu, H., Cheng, X. W., Hu, L., Takeshita, K., Chen, H., Du, Q., Li, X., Zhu, E., Huang, Z., Yisireyili, M., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.307110 · Cited by 81 · see citing works
Myeloid-derived suppressor cells (MDSC): When good intentions go awry
Sanchez‐Pino, M. D., Dean, M. J., & Ochoa, A. C. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104302 · Cited by 72 · see citing works
Regulation of Retinoic Acid Inducible Gene-I (RIG-I) Activation by the Histone Deacetylase 6
Liu, H. M., Jiang, F., Loo, Y., Hsu, S., Hsiang, T.-Y., Marcotrigiano, J., & Gale, M. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.06.015 · Cited by 71 · see citing works
Tsimberidou, A. M., Beer, P. A., Cartwright, C., Haymaker, C., Vo, H. H., Kiany, S., Cecil, A., Dow, J., Haque, K., Silva, F. A., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0238 · Cited by 69 · see citing works
Ariel, O., Gendron, D., Dudemaine, P.-L., Gévry, N. Y., Ibeagha-Awemu, E. M., & Bissonnette, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02874 · Cited by 67 · see citing works
Banik, D., Noonepalle, S. K. R., Hadley, M. M., Palmer, E., Gracia-Hernandez, M., Delgado, C. Z., Manhas, N., Simonyan, H., Young, C. N., Popratiloff, A. S., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3738 · Cited by 67 · see citing works
Self-citationUnexpected implications of STAT3 acetylation revealed by genetic encoding of acetyl-lysine
Belo, Y., Mielko, Z. E., Nudelman, H., Afek, A., Ben‐David, O., Shahar, A., Zarivach, R., Gordân, R., & Arbely, E. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.05.019 · Cited by 65 · see citing works
Targeted inhibition of histone deacetylase 6 in inflammatory diseases
Ran, J., & Zhou, J. (2019) · Thoracic Cancer · doi:10.1111/1759-7714.12974 · Cited by 63 · see citing works
Epigenetic and transcriptional mechanisms for the regulation of IL-10
Zhang, H., & Kuchroo, V. K. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101324 · Cited by 64 · see citing works
Noonepalle, S. K. R., Shen, S., Ptáček, J., Tavares, M. T., Zhang, G., Stránský, J., Pavlı́ček, J., Ferreira, G. M., Hadley, M. M., Pelaez, G. D., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00567 · Cited by 61 · see citing works
Self-citationAlseksek, R. K., Ramadan, W. S. H., Saleh, E., & El‐Awady, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158141 · Cited by 59 · see citing works
Epigenetic regulators of programmed death-ligand 1 expression in human cancers
Kumar, S., & Sharawat, S. K. (2018) · Translational research · doi:10.1016/j.trsl.2018.05.011 · Cited by 51 · see citing works
Role of the HDAC6/STAT3 pathway in regulating PD-L1 expression in osteosarcoma cell lines
Keremu, A., Aimaiti, A., Liang, Z., & Zou, X. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-018-3721-6 · Cited by 53 · see citing works
Targeting Macrophages as a Therapeutic Option in Coronavirus Disease 2019
Gracia-Hernandez, M., Sotomayor, E. M., & Villagra, A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.577571 · Cited by 53 · see citing works
Self-citationModulation of Antitumor Immunity with Histone Deacetylase Inhibitors
McCaw, T. R., Randall, T. D., Forero, A., & Buchsbaum, D. J. (2017) · Immunotherapy · doi:10.2217/imt-2017-0134 · Cited by 48 · see citing works
Histone deacetylase 6 modulates macrophage infiltration during inflammation
Yan, B., Xie, S., Liu, Y., Liu, W., Li, D., Liu, M., Luo, H. R., & Zhou, J. (2018) · Theranostics · doi:10.7150/thno.25317 · Cited by 47 · see citing works
Curriculum vitae of HDAC6 in solid tumors
Zheng, Y., Kang, H., Wang, B., Zhu, Y.-Z., Mamun, M., Zhao, L., Nie, H., Liu, Y., Zhao, L., Zhang, X., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123219 · Cited by 43 · see citing works
Dong, J., Zheng, N., Wang, X., Tang, C. C., Yan, P., Zhou, H., & Huang, J. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.03.026 · Cited by 43 · see citing works
Moonlighting Proteins Are Important Players in Cancer Immunology
Adamo, A., Frusteri, C., Pallotta, M. T., Pirali, T., Sartoris, S., & Ugel, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613069 · Cited by 41 · see citing works
Zhang, S., Bai, X., & Shan, F. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106247 · Cited by 39 · see citing works
Zhang, J., Ma, J., Trinh, R. T. P., Heijnen, C. J., & Kavelaars, A. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.12.005 · Cited by 37 · see citing works
Zhou, D., Choi, Y., & Kim, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-08650-2 · Cited by 35 · see citing works
Wen, Y., Ye, S., Li, Z., Zhang, X., Liu, C., Wu, Y., Zheng, R., Xu, C., Tian, J., Shu, L., et al. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03624-y · Cited by 36 · see citing works
Reddy, S. R., Manjunatha, B., & Lee, S. J. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47090703 · Cited by 34 · see citing works
Maharaj, K. K., Powers, J. J., Mediavilla-Varela, M., Achille, A. N., Gamal, W. M., Quayle, S. N., Jones, S. S., Sahakian, E., & Pinilla-Ibarz, J. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.590072 · Cited by 34 · see citing works
Self-citationHDAC6 as a potential therapeutic target for peripheral nerve disorders
Prior, R. C., Helleputte, L. V., Klingl, Y. E., & Bosch, L. V. D. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1541235 · Cited by 33 · see citing works
Kovalovsky, D., Noonepalle, S. K. R., Suresh, M., Kumar, D., Berrigan, M. J., Gajendran, N., Upadhyay, S., Horvath, A., Kim, A., Quiceno-Torres, D., et al. (2024) · Science Advances · doi:10.1126/sciadv.adp3687 · Cited by 30 · see citing works
Self-citationAcetylation in Tumor Immune Evasion Regulation
Lu, J., He, X., Zhang, L., Zhang, R., & Li, W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.771588 · Cited by 30 · see citing works
Targeting HDAC6 improves anti-CD47 immunotherapy
Gracia-Hernandez, M., Yende, A. S., Gajendran, N., Alahmadi, Z., Li, X., Munoz, Z., Tan, K., Noonepalle, S. K. R., Shibata, M., & Villagra, A. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-02982-4 · Cited by 29 · see citing works
Self-citationHDAC6-Selective Inhibitor Overcomes Bortezomib Resistance in Multiple Myeloma
Lee, S. W., Yeon, S.-K., Kim, G. W., Lee, D. H., Jeon, Y. H., Yoo, J. H., Kim, S. Y., & Kwon, S. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031341 · Cited by 28 · see citing works
Tavares, M. T., Shen, S., Knox, T. J., Hadley, M. M., Kutil, Z., Bařinka, C., Villagra, A., & Kozikowski, A. P. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00223 · Cited by 27 · see citing works
Self-citationZhang, Q.-Q., Zhang, W.-J., & Chang, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1168848 · Cited by 24 · see citing works
Cell therapy using ex vivo reprogrammed macrophages enhances antitumor immune responses in melanoma
Noonepalle, S. K. R., Gracia-Hernandez, M., Aghdam, N., Berrigan, M. J., Coulibaly, H., Li, X., Delgado, C. Z., Pletcher, A., Weselman, B., Palmer, E., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03182-w · Cited by 25 · see citing works
Self-citationSilencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia
Maharaj, K. K., Powers, J. J., Achille, A. N., Deng, S., Fonseca, R., Pabón-Saldaña, M., Quayle, S. N., Jones, S. S., Villagra, A., Sotomayor, E. M., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018020065 · Cited by 23 · see citing works
Self-citationRole of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer
Vuletić, A. M., Martinović, K. M., & Spasić, J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics16010054 · Cited by 24 · see citing works
Immunological Effects of Epigenetic Modifiers
Bezu, L., Chuang, A. W., Liu, P., Kroemer, G., & Kepp, O. (2019) · Cancers · doi:10.3390/cancers11121911 · Cited by 23 · see citing works
Barone, S., Cassese, E., Alfano, A. I., Brindisi, M., & Summa, V. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c02067 · Cited by 22 · see citing works
Peng, X., Yu, Z., Surineni, G., Deng, B., Zhang, M., Li, C., Sun, Z., Pan, W., Liu, Y., Liu, S., et al. (2023) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2023.2201408 · Cited by 21 · see citing works
Retractedde Carvalho, L. M., Wiers, C. E., Sun, H., Wang, G., & Volkow, N. D. (2020) · Brain and Behavior · doi:10.1002/brb3.1961 · Cited by 20 · see citing works
Enhancing Therapeutic Approaches for Melanoma Patients Targeting Epigenetic Modifiers
Gracia-Hernandez, M., Munoz, Z., & Villagra, A. (2021) · Cancers · doi:10.3390/cancers13246180 · Cited by 20 · see citing works
Self-citationRadiotherapy-induced Immune Response Enhanced by Selective HDAC6 Inhibition
Noonepalle, S. K. R., Grindrod, S. C., Aghdam, N., Li, X., Gracia-Hernandez, M., Delgado, C. Z., Jung, M., Villagra, A., & Dritschilo, A. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0215 · Cited by 20 · see citing works
Self-citationMethylation and gene expression of histone deacetylases 6 in systemic lupus erythematosus
Fang, T., Lin, Y., Liu, C., Lin, C., Li, R., Wu, C., Ou, T., Tsai, W., & Yen, J. (2015) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12783 · Cited by 20 · see citing works
Medicinal chemistry insights into non-hydroxamate HDAC6 selective inhibitors
Faridoon, Zha, Y. L., Zhang, G., & Li, J. J. (2022) · Medicinal Chemistry Research · doi:10.1007/s00044-022-02987-8 · Cited by 19 · see citing works
Therapeutic options in Charcot–Marie–Tooth diseases
Mathis, S., Magy, L., & Vallat, J. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1017471 · Cited by 19 · see citing works
Manipulation of the host protein acetylation network by human immunodeficiency virus type 1.
Jeng, M. Y., Ali, I., & Ott, M. (2015) · PubMed · doi:10.3109/10409238.2015.1061973 · Cited by 19 · see citing works
Khetmalis, Y. M., Fathima, A., Schweipert, M., Debarnot, C., Bandaru, N. V. M. R., Murugesan, S., Trinath, J., Meyer‐Almes, F., & Sekhar, K. V. G. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311044 · Cited by 18 · see citing works
New insights into the basic biology of acute graft-versus-host-disease
Li, A. H., Abraham, C., Wang, Y., & Zhang, Y. (2020) · Haematologica · doi:10.3324/haematol.2019.240291 · Cited by 17 · see citing works
Bag, A. K., Schultz, A., Bhimani, S., Stringfield, O., Dominguez, W., Mo, Q., Cen, L., & Adeegbe, D. O. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2042065 · Cited by 16 · see citing works
Histone acetylation modulators in breast cancer
Yuan, X., & Rosen, J. M. (2025) · Breast Cancer Research · doi:10.1186/s13058-025-02006-9 · Cited by 14 · see citing works
Hu, Z., Li, S., He, H., Pan, W., Liu, T., Liang, H., Xu, C., Lu, B., Tao, C., Qi, Z., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02510 · Cited by 13 · see citing works
Epigenetic drug development for autoimmune and inflammatory diseases
Ullah, H., & Khan, H. Z. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816422-8.00017-9 · Cited by 13 · see citing works
Emerging strategies for treating autoimmune disease with genetically modified dendritic cells
Ma, Y., Shi, R., Li, F., & Chang, H. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01641-7 · Cited by 12 · see citing works
Brindisi, M., Barone, S., Rossi, A., Cassese, E., Gaudio, N. D., Morel, Á. J. F., Filocamo, G., Alberico, A., Fino, I. D., Gugliandolo, D., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175349 · Cited by 12 · see citing works
Asaad, L., Pepperrell, B., McErlean, E. M., & Furlong, F. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031274 · Cited by 11 · see citing works
Butler, R. M., McKenzie, R. C. T., Jones, C. L., Flanagan, C. E., Woollard, W. J., Demontis, M. A., Ferreira, S., Tosi, I., John, S., Whittaker, S. J., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.03.1130 · Cited by 11 · see citing works
Interplay between epigenetic and genetic alterations in inborn errors of immunity
Rodríguez‐Ubreva, J., Calvillo, C. L., Satter, L. F., & Ballestar, E. (2023) · Trends in Immunology · doi:10.1016/j.it.2023.09.005 · Cited by 11 · see citing works
Functional Analysis of Histone Deacetylase 11 (HDAC11)
Chen, J., Sahakian, E., Powers, J. J., Lienlaf, M., Perez-Villarroel, P., Knox, T. J., & Villagra, A. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3667-0_11 · Cited by 11 · see citing works
Self-citationZhang, Y., Zhang, G., Wang, Y., Ye, L., Peng, L., Shi, R., Guo, S., He, J., Yang, H., & Dai, Q. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1324859 · Cited by 10 · see citing works
Zwick, V., Simões‐Pires, C. A., & Cuendet, M. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2016.1180595 · Cited by 10 · see citing works
Expression and Function of Histone Deacetylase 10 (HDAC10) in B Cell Malignancies
Powers, J. J., Lienlaf, M., Perez-Villarroel, P., Deng, S., Knox, T. J., Villagra, A., & Sahakian, E. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3667-0_10 · Cited by 10 · see citing works
Self-citationContribution of Histone Deacetylases in Prognosis and Therapeutic Management of Cholangiocarcinoma
Mastoraki, A. T., Schizas, D., Charalampakis, N., Naar, L., Ioannidi, M., Tsilimigras, D. I., Sotiropoulou, M. G., Moris, D., Vassiliu, P., & Felekouras, E. S. (2020) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-020-00454-x · Cited by 10 · see citing works
Wen, H., Gallo, R. A., Huang, X., Cai, J., Mei, S., Farooqı, A. A., Zhao, J., & Tao, W. (2021) · Journal of Ophthalmology · doi:10.1155/2021/5580595 · Cited by 9 · see citing works
Editorial: Genetic and Epigenetic Control of Immune Responses
Noonepalle, S. K. R., Karabon, L., Chiappinelli, K. B., & Villagra, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.775101 · Cited by 8 · see citing works
Self-citationAdeegbe, D. O., Bag, A. K., Schultz, A., Bhimani, S., Dominguez, W., & Cen, L. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.208.supp.118.11 · Cited by 7 · see citing works
Lower HDAC6 mRNA expression and promoter hypomethylation are associated with RA susceptibility
Fang, T., Lin, C., Lin, Y., Chiu, M., Li, R., Chan, H., Yeh, Y., & Yen, J. (2021) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2021.10.008 · Cited by 6 · see citing works
HDAC6: Tumor Progression and Beyond
Oliveira‐Silva, J. M., Oliveira, L. S., Tagliéri, J. V. M., Lopes, L. B., de Souza, C. V. E., Batistão, H. K. D. A., & Castro‐Gamero, A. M. (2025) · Current Cancer Drug Targets · doi:10.2174/0115680096332732241113053459 · Cited by 5 · see citing works
Zhao, Y., Xuan, H., Shen, C., Liu, P., Han, J. J., & Yu, W. (2022) · Phenomics · doi:10.1007/s43657-022-00045-2 · Cited by 5 · see citing works
Present and future perspectives for targeting histone modifications in therapy
Camilo, V., & Jerónimo, C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816422-8.00018-0 · Cited by 4 · see citing works
Peng, J., Yang, J., Antonopoulou, G., Fang, R., Adhikari, B., Vogt, M., Wolf, E., Sun, C., Du, S., Godfrey, L., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69013-y · Cited by 3 · see citing works
Impact of epigenetic modifiers on the immune system
Bhat, S. A., Sureshbabu, S. K., Philip, C. S., & Chiplunkar, S. V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817964-2.00014-9 · Cited by 3 · see citing works
Kim, C. E., Lee, S.-M., Yoon, E. H., Won, H. J., Jung, Y. J., Jegal, Y., Kim, D., Kwon, B., & Seo, S. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112246 · Cited by 3 · see citing works
Luong, P. Q., Lee, G. B., & Kim, J. I. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150800 · Cited by 1 · see citing works
Bag, A. K., Schultz, A., Bhimani, S., Dominguez, W., Cen, L., & Adeegbe, D. O. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.01.462824 · Cited by 1 · see citing works
DNA Methylation and Histone Modifications in Autoimmunity
Banik, D., Chiappinelli, K. B., & Villagra, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809912-4.00003-9
Self-citationTogay, A., Başok, B. İ., Çolak, A., & Yılmaz, N. (2023) · Journal of Medicine and Palliative Care · doi:10.47582/jompac.1317134
WITHDRAWN: Epigenetic remodeling of the myeloid landscape of the cancer tumor microenvironment
German, B., Petkovich, D. A., & Ellis, L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.00002-3
Epigenetic remodeling of the myeloid landscape of the cancer tumor microenvironment
German, B., Petkovich, D. A., & Ellis, L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14064-8.90002-x
Additional file 1 of Targeting HDAC6 improves anti-CD47 immunotherapy
Gracia-Hernandez, M., Yende, A. S., Gajendran, N., Alahmadi, Z., Li, X., Munoz, Z., Tan, K., Noonepalle, S. K. R., Shibata, M., & Villagra, A. (2024) · Figshare · doi:10.6084/m9.figshare.25303067
Self-citation
- Authors
- Cheng, F., Lienlaf, M., Wang, H.-W., Perez-Villarroel, P., Lee, C., Woan, K., Rock-Klotz, J., Sahakian, E., Woods, D., Pinilla-Ibarz, J., Kalin, J., Tao, J., Hancock, W., Kozikowski, A., Seto, E., Villagra, A., & Sotomayor, E. M.
- Affiliations
- Moffitt Cancer Center (US)
- Department of Immunology and Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute , Tampa, FL 33612
- Johns Hopkins University (US)
- University of Illinois Chicago (US)
- University of Pennsylvania (US)
- Corresponding author
- Cheng, Fengdong
- Lienlaf, Maritza
- Woan, Karrune
- Sahakian, Eva
- Woods, David
- Tao, Jianguo
- Villagra, Alejandro
- ORCID
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-09
- Volume
- 193
- Issue
- 6
- Pages
- 2850-2862
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC4157123
- OpenAlex
- W2151850046
- Cited by
- 106
- References
- 64
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 12 · 2023: 8 · 2022: 7 · 2021: 11 · 2020: 15 · 2019: 12 · 2018: 11 · 2017: 6 · 2016: 8 · 2015: 5
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R21CA184612, R01CA087583, CA134807, T32CA115308, R01CA134807, R21CA153246, R01CA100850, CA87583, CA100850, P30CA076292)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
- Keywords
- HDAC6, STAT3, IL-10, antigen-presenting cells, dendritic cells, macrophages, T cell tolerance, STAT3 phosphorylation, epigenetic regulation, HDAC6 inhibitors, T cell activation
- MeSH terms
- Histone Deacetylase 6, Acetylation, Animals, Antigen-Presenting Cells, Cell Line, Dendritic Cells, Gene Expression Regulation, Histone Deacetylases, Immune Tolerance, Inflammation, Lymphocyte Activation, Macrophages, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Mutation, Oligopeptides, Phosphorylation, Promoter Regions, Genetic, Recombinant Proteins, Transcription, Genetic, CD4-Positive T-Lymphocytes, Gene Expression, Interleukin-10, Protein Structure, Tertiary, Mice, Knockout, RNA Interference, RNA, Small Interfering, Chromatin Immunoprecipitation, STAT3 Transcription Factor, Mice, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
